U.S. Biliary Stents Market Outlook - 2025

The U.S. biliary stents market was valued at $316 million in 2017, and is expected to reach $474 million by 2025. U.S. biliary stents market is anticipated to grow at a CAGR of 5.2% during the forecast period. A biliary stent is a plastic or metal tube that is inserted into a bile duct to palliate narrowing of the duct.

Bile is a substance that aids in digestion of fats. It is produced by the liver and stored in the gallbladder. Bile is secreted through the bile ducts. This substance is released into the small intestine after eating a fat-containing meal. There are numerous different conditions that are responsible for causing strictures of the bile duct. Some of them include pancreatic cancer, cancers of the liver, bile duct, large intestine, & gallbladder, pancreatitis, gallstones, radiation therapy, and others.

Get more information on this report : Request Sample Pages

The U.S. biliary stents market growth is anticipated to rise gradually throughout the forecast period. This is attributed to the fact that the prevalence of biliary disease is rising in the U.S. Biliary diseases include various conditions such as benign biliary strictures gallbladder disease, biliary tract disease, acalculous cholecystitis, choledocholithiasis, cholangiocarcinoma, and others. There is a considerable increase in the prevalence of this disease. Estimates from the National Pancreas Foundation (2019) suggest that the prevalence of chronic pancreatitis is 50 in 100,000 people. Furthermore, surge in awareness with respect to different biliary diseases also promotes the growth of the market.

The increase in availability of an array of different types of biliary stents is anticipated to boost the U.S. biliary rents market during the forecast period. Likewise, technological advancements associated with biliary stents along with surge in demand for minimally invasive procedures are also expected to augment the market growth in the forecast period. However, complications associated with biliary stent placement and high costs associated with biliary stents are anticipated to impede the market during the forecast period. However, the development of innovative digital solutions and smartphone applications for biliary stent management is anticipated to provide lucrative opportunities to the key players in the U.S. biliary stents market.

Get more information on this report : Request Sample Pages

The report covers the U.S. biliary stents market forecast and analysis based on three categories that include type, application, and end user. Based on type, the market is categorized into metal biliary stents, and plastic biliary stents. On the basis of application, it is categorized into malignant obstruction, benign biliary strictures, biliary leaks, and others. By end user, the market is bifurcated into hospitals and ambulatory surgical centers.

Get more information on this report : Request Sample Pages

The U.S. biliary stents market opportunity is analyzed by the type vertical graph in the report. By type, the metal biliary stents segment occupied the largest share in 2017, and this trend is expected to continue throughout the forecast period owing to the wide application of specialized metal stents such as self-expandable metal stents (SEMs) in treatment of biliary comorbidities. In addition, metal stents with larger diameters have desirable features such as an increased patency duration, which make them one of the most sought-after choices for stenting.

The U.S. biliary stents market share is also analyzed through application. By application, the biliary leaks segment occupied the largest share in 2017. Biliary leaks are one of the most common modalities that are treated using stents. A small hole along the bile ducts can cause bile to leak into the abdominal cavity. A bile duct leak can form either a complication of a surgery, such as liver transplant, or through gallbladder removal, or from trauma to the biliary system.

Get more information on this report : Request Sample Pages

Furthermore, the U.S. biliary stents market trends are also analyzed through end users. By end user, the hospital segment is anticipated to occupy the largest share in 2025. The hospital segment generates maximum revenue from the surgical procedures, and is estimated to continue its dominance during the forecast period. Furthermore, the availability of trained medical staff in hospitals helps provide better services to the patient, which further contributes toward the growth of the market.

The growing competition and continuous technological advancements have led to agreements by major players in the biliary stents market. For instance, in May 2018, Olympus Corporation signed an exclusive deal to distribute M.I. Techs Hanarostent self-expanding metal stents. The deal includes both the FDA 510(k) cleared Hanarostent biliary and Hanarostent esophagus stents,

There have also been considerable product developments in the industry. For instance, in March 2016, Boston Scientific launched the AXIOS Stent and Delivery System. It is an endoscopic system indicated for the minimally invasive treatment of complications from pancreatitis. These devices were developed by Xlumena, which was acquired by Boston Scientific Corporation in 2015.

The major companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Conmed Corporation, Cook Medical, B. Braun Melsungen AG, Medtronic plc, Terumo Corporation, Merit Medical, Olympus Corporation, and Becton, Dickinson and Company. The other players included in the value chain analysis (but not included in the report) are Taewoong Medical Co., Ltd., Biosensors International Group, Ltd., and others.

Key Benefits for U.S. biliary stents market:

• The report provides an extensive analysis of the current market trends and future estimations of the U.S. biliary stents market.
• The U.S. biliary stents market top player positioning is comprehensively analyzed in the report.
• The U.S. biliary stents market share is comprehensively analyzed with respect to the application, type, and end user.
• U.S. biliary market growth analysis by type helps understand the significance of the different types of biliary stents available in the market.
• Key manufacturers involved in the U.S. biliary stents market are listed and analyzed in this report to understand the competitive scenario of the market.

 Key Market Segments

• By Type
  • Metal biliary stents
  • Plastic biliary stents
• By Application
  • Malignant obstruction
  • Benign biliary strictures
  • Biliary leaks
  • Others
• By End User
  • Hospitals
  • Ambulatory surgical centers

 
Key Market Players

• MEDTRONIC PLC
• TERUMO MEDICAL CORPORATION
• OLYMPUS CORPORATION
• ABBOTT LABORATORIES
• COOK MEDICAL INC.
• B. BRAUN MELSUNGEN AG
• MERIT MEDICAL SYSTEMS, INC.
• BECTON, DICKINSON AND COMPANY
• CONMED CORPORATION
• BOSTON SCIENTIFIC CORPORATION

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key Benefits for Stakeholders
1.3.    Key Market Segments

1.3.1.    List of players profiled in the report

1.4.    Research Methodology

1.4.1.    Secondary research
1.4.2.    Primary research
1.4.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    Key Findings of the Study
2.2.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Key findings

3.2.1.    Top investment pockets

3.3.    Top player positioning, 2017
3.4.    Porter’s five forces analysis
3.5.    Market dynamics

3.5.1.    Drivers

3.5.1.1.    High prevalence of biliary diseases
3.5.1.2.    Technological advancements associated with biliary stents and urge in demand for minimally invasive procedures

3.5.2.    Restraint

3.5.2.1.    Complications and high costs associated with biliary stents

3.5.3.    Opportunity

3.5.3.1.    Development of innovative smartphone applications

CHAPTER 4:    U.S. BILIARY STENTS MARKET, BY TYPE

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Metal Biliary Stents

4.2.1.    Key market trends, growth factors, and opportunities
4.2.2.    Market size and forecast

4.3.    Plastic Biliary Stents

4.3.1.    Key market trends, growth factors, and opportunities
4.3.2.    Market size and forecast

CHAPTER 5:    U.S. BILIARY STENTS MARKET, BY APPLICATION

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Malignant obstruction

5.2.1.    Market size and forecast

5.3.    Benign biliary strictures

5.3.1.    Market size and forecast

5.4.    Biliary leaks

5.4.1.    Market size and forecast

5.5.    Others

5.5.1.    Market size and forecast

CHAPTER 6:    U.S. BILIARY STENTS MARKET, BY END USER

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    Hospitals

6.2.1.    Market size and forecast

6.3.    Ambulatory surgical centers

6.3.1.    Market size and forecast

CHAPTER 7:    COMPANY PROFILES

7.1.    ABBOTT LABORATORIES

7.1.1.    Company overview
7.1.2.    Company snapshot
7.1.3.    Operating business segments
7.1.4.    Product portfolio
7.1.5.    Business performance

7.2.    B. BRAUN MELSUNGEN AG

7.2.1.    Company overview
7.2.2.    Company snapshot
7.2.3.    Operating business segments
7.2.4.    Product portfolio
7.2.5.    Business performance

7.3.    BECTON, DICKINSON AND COMPANY

7.3.1.    Company overview
7.3.2.    Company snapshot
7.3.3.    Operating business segments
7.3.4.    Product portfolio
7.3.5.    Business performance

7.4.    BOSTON SCIENTIFIC CORPORATION

7.4.1.    Company overview
7.4.2.    Company snapshot
7.4.3.    Operating business segments
7.4.4.    Product Portfolio
7.4.5.    Business performance

7.5.    COOK MEDICAL INC.

7.5.1.    Company overview
7.5.2.    Company snapshot
7.5.3.    Operating business segments
7.5.4.    Product portfolio

7.6.    CONMED CORPORATION

7.6.1.    Company overview
7.6.2.    Company snapshot
7.6.3.    Operating business segments
7.6.4.    Business performance
7.6.5.    Product portfolio

7.7.    MEDTRONIC PLC

7.7.1.    Company overview
7.7.2.    Company snapshot
7.7.3.    Operating business segments
7.7.4.    Product portfolio
7.7.5.    Business performance

7.8.    MERIT MEDICAL SYSTEMS, INC.

7.8.1.    Company overview
7.8.2.    Company snapshot
7.8.3.    Operating business segments
7.8.4.    Product portfolio
7.8.5.    Business performance

7.9.    OLYMPUS CORPORATION

7.9.1.    Company overview
7.9.2.    Company snapshot
7.9.3.    Operating business segments
7.9.4.    Product Portfolio
7.9.5.    Business performance

7.10.    TERUMO MEDICAL CORPORATION

7.10.1.    Company overview
7.10.2.    Company snapshot
7.10.3.    Operating business segments
7.10.4.    Product portfolio
7.10.5.    Business performance

LIST OF TABLES

TABLE 01.    U.S. BILIARY STENTS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 02.    U.S. BILIARY STENTS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 03.    U.S. BILIARY STENTS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 04.    ABBOTT: COMPANY SNAPSHOT
TABLE 05.    ABBOTT: OPERATING SEGMENTS
TABLE 06.    ABBOTT: PRODUCT PORTFOLIO
TABLE 07.    B. BRAUN: COMPANY SNAPSHOT
TABLE 08.    B. BRAUN: OPERATING SEGMENTS
TABLE 09.    B. BRAUN: PRODUCT PORTFOLIO
TABLE 10.    BD: COMPANY SNAPSHOT
TABLE 11.    BD: OPERATING SEGMENTS
TABLE 12.    B. BRAUN: PRODUCT PORTFOLIO
TABLE 13.    BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 14.    BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 15.    BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 16.    COOK MEDICAL: COMPANY SNAPSHOT
TABLE 17.    COOK MEDICAL: OPERATING SEGMENTS
TABLE 18.    COOK MEDICAL: PRODUCT PORTFOLIO
TABLE 19.    CONMED CORPORATION: COMPANY SNAPSHOT
TABLE 20.    CONMED CORPORATION: OPERATING SEGMENTS
TABLE 21.    CONMED: PRODUCT PORTFOLIO
TABLE 22.    MEDTRONIC: COMPANY SNAPSHOT
TABLE 23.    MEDTRONIC: OPERATING SEGMENTS
TABLE 24.    MEDTRONIC: PRODUCT PORTFOLIO
TABLE 25.    MERIT: COMPANY SNAPSHOT
TABLE 26.    MERIT: OPERATING SEGMENTS
TABLE 27.    MERIT: PRODUCT PORTFOLIO
TABLE 28.    OLYMPUS CORPORATION.: COMPANY SNAPSHOT
TABLE 29.    OLYMPUS CORPORATION.: OPERATING SEGMENTS
TABLE 30.    OLYMPUS CORPORATION.: PRODUCT PORTFOLIO
TABLE 31.    TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 32.    TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 33.    TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.    U.S. BILIARY STENTS MARKET SEGMENTATION
FIGURE 02.    TOP INVESTMENT POCKETS
FIGURE 03.    TOP PLAYER POSITIONING, 2017
FIGURE 04.    LOW BARGAINING POWER OF BUYERS
FIGURE 05.    MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06.    LOW THREAT OF NEW ENTRANTS
FIGURE 07.    MODERATE THREAT OF SUBSTITUTION
FIGURE 08.    HIGH COMPETITIVE RIVALRY
FIGURE 09.    MARKET DRIVERS, RESTRAINT, AND OPPORTUNITY
FIGURE 10.    U.S. BILIARY STENTS MARKET FOR METAL BILIARY STENTS, 2017–2025 ($MILLION)
FIGURE 11.    U.S. BILIARY STENTS MARKET FOR PLASTIC BILIARY STENTS, 2017–2025 ($MILLION)
FIGURE 12.    U.S. BILIARY STENTS MARKET FOR MALIGNANT OBSTRUCTION, 2017-2025 ($MILLION)
FIGURE 13.    U.S. BILIARY STENTS MARKET FOR BENIGN BILIARY STRICTURES, 2017-2025 ($MILLION)
FIGURE 14.    U.S. BILIARY STENTS MARKET FOR BELIARY LEAKS, 2017-2025 ($MILLION)
FIGURE 15.    U.S. BILIARY STENTS MARKET FOR OTHERS, 2017-2025 ($MILLION)
FIGURE 16.    U.S. BILIARY STENTS MARKET FOR HOSPITALS, 2017-2025 ($MILLION)
FIGURE 17.    U.S. BILIARY STENTS MARKET FOR AMBULATORY SURGICAL CENTERS, 2017-2025 ($MILLION)
FIGURE 18.    ABBOTT: NET SALES, 2015–2017 ($MILLION)
FIGURE 19.    ABBOTT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 20.    ABBOTT: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 21.    B. BRAUN: NET SALES, 2015–2017($MILLION)
FIGURE 22.    B. BRAUN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 23.    B. BRAUN: REVENUE SHARE BY REGION, 2017(%)
FIGURE 24.    BD: NET SALES, 2015–2017 ($MILLION)
FIGURE 25.    BD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 26.    BD: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 27.    BOSTON SCIENTIFIC: NET SALES, 2015–2017 ($MILLION)
FIGURE 28.    BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 29.    BOSTON SCIENTIFIC: NET SALES, BY REGION, 2017 (%)
FIGURE 30.    CONMED CORPORATION.: REVENUE, 2015–2017 ($MILLION)
FIGURE 31.    CONMED CORPORATION.: REVENUE SHARE BY BUSINESS SEGMENT, 2017 (%)
FIGURE 32.    CONMED CORPORATION: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 33.    MEDTRONIC: NET SALES, 2015–2017 ($MILLION)
FIGURE 34.    MEDTRONIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 35.    MEDTRONIC: NET SALES, BY REGION, 2017 (%)
FIGURE 36.    MERIT: NET SALES, 2014–2016 ($MILLION)
FIGURE 37.    MERIT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 38.    MERIT: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 39.    OLYMPUS CORPORATION: REVENUE, 2016–2018 ($MILLION)
FIGURE 40.    OLYMPUS CORPORATION: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 41.    OLYMPUS CORPORATION: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 42.    TERUMO MEDICAL CORPORATION: NET SALES, 2015–2017 ($MILLION)
FIGURE 43.    TERUMO MEDICAL CORPORATION: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 44.    TERUMO MEDICAL CORPORATION: REVENUE SHARE BY REGION, 2016 (%)